Status:
TERMINATED
Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition
Lead Sponsor:
Johns Hopkins University
Conditions:
CLABSI - Central Line Associated Bloodstream Infection
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
This study an open label prospective observational cohort study to evaluate the safety and efficacy of sodium citrate 4% locking solution in preventing central line associated blood stream infection i...
Detailed Description
In this prospective observational cohort study of pediatric patients requiring home parenteral nutrition for intestinal failure, participants will be enrolled from the pediatric intestinal rehabilitat...
Eligibility Criteria
Inclusion
- Pediatric patients (\<18 years) and adult patients (up to 21 years still in our clinic)
- requiring long-term (\>3 months) home parenteral nutrition due to intestinal failure/short bowel syndrome
- has had at least one central line-associated blood stream infection
Exclusion
- known cardiac arrhythmias
- hypersensitivity to citrate
- pregnancy
- receiving continuous parenteral nutrition (infusing over 24 hours)
Key Trial Info
Start Date :
March 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04756427
Start Date
March 28 2022
End Date
November 28 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins
Baltimore, Maryland, United States, 21131